Viewing Study NCT05510466


Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2026-01-05 @ 6:14 PM
Study NCT ID: NCT05510466
Status: UNKNOWN
Last Update Posted: 2022-08-22
First Post: 2022-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis
Sponsor: University Hospital, Montpellier
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module